Mesirow Financial Investment Management Equity & Fixed Income Emergent Bio Solutions Inc. Transaction History

Mesirow Financial Investment Management Equity & Fixed Income

$114 Million
Q2 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$27.42 - $43.63 $109,268 - $173,865	-3,985 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$36.48 - $52.22 $3,100 - $4,438	-85 Reduced 2.09%	3,985 $164,000
Q4 2021 Feb 07, 2022	BUY	$33.11 - $55.01 $134,757 - $223,890	4,070 New	4,070 $177,000

Others Institutions Holding EBS

# of Institutions

154

Shares Held

30.2M

Call Options Held

137K

Put Options Held

706K

Black Rock Inc. New York, NY

3.84M
Shares

$32.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.67M
Shares

$31.1 Million
0.0% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

3.17M
Shares

$26.8 Million
0.0% of portfolio
Morgan Stanley New York, NY

1.24M
Shares

$10.5 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

946K
Shares

$8.02 Million
0.0% of portfolio

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $422M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management Equity & Fixed Income, based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management Equity & Fixed Income with notifications on news.

Account